Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the BioTech industry. This time, you get to discover 5 hand-picked BioTech startups developing Artificial Intelligence-powered solutions.
Global Startup Heat Map highlights 5 Top Artificial Intelligence Startups out of 297
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence-powered StartUs Insights Discovery Platform, covering 1.379.000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 297 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 BioTech startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 292 AI-powered solutions, get in touch.
Digi Bio provides Microfluidic Automation
Microfluidics technology faces many challenges such as the accurate measurement of subtle interactions of components of a reaction. However, their properties have a wide range of applications; from high throughput screening technologies to point-of-care diagnostics & more. More recently, the advent of artificial intelligence enables automation and helps predict experimental parameters including flow rate or concentrations to generate size-tunable particles with specific characteristics.
Digi Bio is a Dutch startup developing lab-on-a-chip (LOC) technology. The startup combines AI and microfluidics to provide digital microfluidics for rapid and precise manipulation of nanoscale droplets. Digi Bio utilizes electrowetting technology, which facilitates control over fluid flow and shape on an electrode array. This aids in the automated execution of complex biological protocols.
Varstation works on Next-Generation Sequencing (NGS) Analysis
NGS techniques find applications in genotyping and diagnostics, among others. However, the analysis and interpretation of mutations is essential for NGS applications. This is why AI-based platforms leverage databases of mutations, both germline and somatic, to enable swift interpretation. These tools further feature flexible filters such as characteristics of the variants, including phenotypes, clinical history of the patient, and diseases in order to provide personalized analysis.
Brazilian startup Varstation specializes in processing and analyzing NGS data from human genetic samples. The startup develops VarsACMG and VarsSmartFilter, proprietary AI-based platforms. VarsACMG uses machine learning algorithms and a proprietary database to perform analysis of NGS data. VarsSmartFilter provides a user-friendly graphical interface with filters for germline or somatic mutations, genomic location, type, frequency, genotype, damage prediction, molecular functions, and biological processes. It offers a flexible solution to perform customized analysis of variants and their pathogenicity level.
Ares Genetics analyzes Antimicrobial Resistance (AMR)
Preventing the spread of infectious diseases requires accurate and precise tools for diagnosis. Additionally, the detection of antimicrobial resistance (AMR) is also necessary to administer appropriate drugs to which the infection is susceptible. Gene-based biomarkers aid in screening for antimicrobial resistance. This is why startups develop AI-based tools with databases of resistance markers to enable rapid and accurate analysis of patient samples.
Ares Genetics is an Austrian startup developing multiple AI-based software solutions for antimicrobial resistance analysis. ARESdb, the startup’s in-vitro diagnostics (IVD) reference database, provides proprietary knowledge based on genetic antibiotic resistance markers and their diagnostic relevance. AREScds is a cloud-based and HIPAA-compliant decision support & reporting system that links antimicrobial resistance markers to treatment response. Lastly, ARESupa is a universal pathogenome assay (UPA) for any patient sample.
GenomeUp enables Precision Medicine
Personalized medicine requires the integration of BioTech research and clinical data. Here, AI enables the analysis of whole-genome sequencing data of the patient together with the demographic information to provide valuable insights on specific genes. AI-based tools help the identification of new mutations and provide specific information for precision medicine.
Italian startup GenomeUp offers an AI-powered precision medicine platform. The startup’s genomics tool analyzes a patient’s whole-genome sequencing data (WGS) for personalized therapies. The platform enables doctors to obtain a detailed clinical report on genes affecting the patient. It also provides insights on selected mutations and new mutations which appear during disease progression and suggests personalized treatments.
NeoGenome offers Sustainable Chemical Production
The production of chemicals from petrochemicals and their derivatives pollute the environment. Moreover, such chemicals are generally non-biodegradable and contribute to carbon emissions. Engineered microbes, however, enable a sustainable and eco-friendly chemical production of chemicals. To this end, AI facilitates the analysis and interpretation of genes of microbes for gene modification, as well as provides insights into the byproducts of metabolic pathways.
British startup NeoGenome creates genetically modified microorganisms to produce low-cost chemicals. The startup utilizes AI to analyze and modify microbes. The startup’s engineered microbe-based commercial product produces lactic acid at 40% less cost than the conventional bacterial fermentation process. NeoGenome’s non-toxic product lines address the environmental impact of landfills and pollution.
Discover more BioTech Startups
BioTech startups such as the examples highlighted in this report focus on biomanufacturing, tissue engineering, alternative proteins as well as gene editing. While all of these technologies play a major role in advancing the BioTech sector, they only represent the tip of the iceberg. To explore more technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free BioTech Innovation Report to save your time and improve strategic decision-making.